Clinical Trial Update: Neoadjuvant Iparomlimab and Tuvonralimab Plus Chemotherapy-eclipse for Locally Advanced Cervical Cancer (NICE-CC) [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant trial evaluating the combination of Iparomlimab and Tuvonralimab with chemotherapy for locally advanced cervical cancer is currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Tuvonralimab (tuvonralimab)
• iparomlimab

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Locally Advanced Cervical Cancer | Phase 2 | Status: RECRUITING